% Options for packages loaded elsewhere
\PassOptionsToPackage{unicode}{hyperref}
\PassOptionsToPackage{hyphens}{url}
%
\documentclass[
]{article}
\usepackage{amsmath,amssymb}
\usepackage{iftex}
\ifPDFTeX
  \usepackage[T1]{fontenc}
  \usepackage[utf8]{inputenc}
  \usepackage{textcomp} % provide euro and other symbols
\else % if luatex or xetex
  \usepackage{unicode-math} % this also loads fontspec
  \defaultfontfeatures{Scale=MatchLowercase}
  \defaultfontfeatures[\rmfamily]{Ligatures=TeX,Scale=1}
\fi
\usepackage{lmodern}
\ifPDFTeX\else
  % xetex/luatex font selection
\fi
% Use upquote if available, for straight quotes in verbatim environments
\IfFileExists{upquote.sty}{\usepackage{upquote}}{}
\IfFileExists{microtype.sty}{% use microtype if available
  \usepackage[]{microtype}
  \UseMicrotypeSet[protrusion]{basicmath} % disable protrusion for tt fonts
}{}
\makeatletter
\@ifundefined{KOMAClassName}{% if non-KOMA class
  \IfFileExists{parskip.sty}{%
    \usepackage{parskip}
  }{% else
    \setlength{\parindent}{0pt}
    \setlength{\parskip}{6pt plus 2pt minus 1pt}}
}{% if KOMA class
  \KOMAoptions{parskip=half}}
\makeatother
\usepackage{xcolor}
\usepackage[margin=1in]{geometry}
\usepackage{graphicx}
\makeatletter
\def\maxwidth{\ifdim\Gin@nat@width>\linewidth\linewidth\else\Gin@nat@width\fi}
\def\maxheight{\ifdim\Gin@nat@height>\textheight\textheight\else\Gin@nat@height\fi}
\makeatother
% Scale images if necessary, so that they will not overflow the page
% margins by default, and it is still possible to overwrite the defaults
% using explicit options in \includegraphics[width, height, ...]{}
\setkeys{Gin}{width=\maxwidth,height=\maxheight,keepaspectratio}
% Set default figure placement to htbp
\makeatletter
\def\fps@figure{htbp}
\makeatother
\setlength{\emergencystretch}{3em} % prevent overfull lines
\providecommand{\tightlist}{%
  \setlength{\itemsep}{0pt}\setlength{\parskip}{0pt}}
\setcounter{secnumdepth}{-\maxdimen} % remove section numbering
\usepackage{booktabs}
\usepackage{caption}
\usepackage{longtable}
\usepackage{colortbl}
\usepackage{array}
\ifLuaTeX
  \usepackage{selnolig}  % disable illegal ligatures
\fi
\usepackage{bookmark}
\IfFileExists{xurl.sty}{\usepackage{xurl}}{} % add URL line breaks if available
\urlstyle{same}
\hypersetup{
  pdftitle={ANALYSIS},
  pdfauthor={Max Gurtler},
  hidelinks,
  pdfcreator={LaTeX via pandoc}}

\title{ANALYSIS}
\usepackage{etoolbox}
\makeatletter
\providecommand{\subtitle}[1]{% add subtitle to \maketitle
  \apptocmd{\@title}{\par {\large #1 \par}}{}{}
}
\makeatother
\subtitle{SEN-B}
\author{Max Gurtler}
\date{2024-05-27}

\begin{document}
\maketitle

\begin{verbatim}
## Loading required package: pacman
\end{verbatim}

\section{TABLE 1}\label{table-1}

\setlength{\LTpost}{0mm}
\begin{longtable}{lcccc}
\toprule
 & \multicolumn{2}{c}{\textbf{CCA Result}} &  &  \\ 
\cmidrule(lr){2-3}
\textbf{Variable} & \textbf{Female}, N = 372\textsuperscript{\textit{1}} & \textbf{Male}, N = 427\textsuperscript{\textit{1}} & \textbf{Total} (N = 799)\textsuperscript{\textit{1}} & \textbf{p-value}\textsuperscript{\textit{2}} \\ 
\midrule\addlinespace[2.5pt]
\textbf{Screening Year} &  &  &  & 0.46 \\ 
    2019 & 42 / 372 (11\%) & 40 / 427 (9.4\%) & 82 / 799 (10\%) &  \\ 
    2020 & 29 / 372 (7.8\%) & 30 / 427 (7.0\%) & 59 / 799 (7.4\%) &  \\ 
    2021 & 183 / 372 (49\%) & 226 / 427 (53\%) & 409 / 799 (51\%) &  \\ 
    2022 & 117 / 372 (31\%) & 126 / 427 (30\%) & 243 / 799 (30\%) &  \\ 
    2023 & 1 / 372 (0.3\%) & 5 / 427 (1.2\%) & 6 / 799 (0.8\%) &  \\ 
\textbf{Age} &  &  &  & 0.98 \\ 
    18-31 & 179 / 372 (48\%) & 205 / 427 (48\%) & 384 / 799 (48\%) &  \\ 
    >31 & 193 / 372 (52\%) & 222 / 427 (52\%) & 415 / 799 (52\%) &  \\ 
\textbf{Origin} &  &  &  & 0.12 \\ 
    <1\% prevalence (non-endemic) & 143 / 366 (39\%) & 130 / 414 (31\%) & 273 / 780 (35\%) &  \\ 
    1-9.9\% prevalence (low) & 78 / 366 (21\%) & 105 / 414 (25\%) & 183 / 780 (23\%) &  \\ 
    10-49\% prevalence (moderate) & 103 / 366 (28\%) & 124 / 414 (30\%) & 227 / 780 (29\%) &  \\ 
    ≥50\% prevalence (high) & 32 / 366 (8.7\%) & 48 / 414 (12\%) & 80 / 780 (10\%) &  \\ 
    Other Country & 10 / 366 (2.7\%) & 7 / 414 (1.7\%) & 17 / 780 (2.2\%) &  \\ 
\textbf{Residence} &  &  &  & 0.49 \\ 
    Dakar & 295 / 372 (79\%) & 347 / 427 (81\%) & 642 / 799 (80\%) &  \\ 
    Outside & 77 / 372 (21\%) & 80 / 427 (19\%) & 157 / 799 (20\%) &  \\ 
\textbf{Alcohol Consumption} &  &  &  & 0.002 \\ 
    Yes\_past & 3 / 361 (0.8\%) & 18 / 404 (4.5\%) & 21 / 765 (2.7\%) &  \\ 
    No & 358 / 361 (99\%) & 386 / 404 (96\%) & 744 / 765 (97\%) &  \\ 
\textbf{AUDIT-C Score} &  &  &  & 0.037 \\ 
    Misuse & 3 / 372 (0.8\%) & 12 / 427 (2.8\%) & 15 / 799 (1.9\%) &  \\ 
    Negative & 369 / 372 (99\%) & 415 / 427 (97\%) & 784 / 799 (98\%) &  \\ 
\textbf{Dipstick EtG} &  &  &  & 0.49 \\ 
    Negative & 261 / 329 (79\%) & 319 / 392 (81\%) & 580 / 721 (80\%) &  \\ 
    Positive & 68 / 329 (21\%) & 73 / 392 (19\%) & 141 / 721 (20\%) &  \\ 
\textbf{Drug Consumption} &  &  &  & <0.001 \\ 
    Yes\_now & 0 / 372 (0\%) & 0 / 427 (0\%) & 0 / 799 (0\%) &  \\ 
    Yes\_past & 0 / 372 (0\%) & 13 / 427 (3.0\%) & 13 / 799 (1.6\%) &  \\ 
    No & 372 / 372 (100\%) & 414 / 427 (97\%) & 786 / 799 (98\%) &  \\ 
\textbf{Smoking} &  &  &  & <0.001 \\ 
    Yes\_now & 2 / 372 (0.5\%) & 16 / 427 (3.7\%) & 18 / 799 (2.3\%) &  \\ 
    Yes\_past & 2 / 372 (0.5\%) & 69 / 427 (16\%) & 71 / 799 (8.9\%) &  \\ 
    No & 368 / 372 (99\%) & 342 / 427 (80\%) & 710 / 799 (89\%) &  \\ 
\textbf{Hypertension} & 83 / 372 (22\%) & 109 / 427 (26\%) & 192 / 799 (24\%) & 0.29 \\ 
\textbf{Diabetes} & 9 / 372 (2.4\%) & 13 / 427 (3.0\%) & 22 / 799 (2.8\%) & 0.59 \\ 
\textbf{BMI} &  &  &  & <0.001 \\ 
    Normal Weight & 170 / 365 (47\%) & 289 / 426 (68\%) & 459 / 791 (58\%) &  \\ 
    Underweight & 44 / 365 (12\%) & 73 / 426 (17\%) & 117 / 791 (15\%) &  \\ 
    Overweight & 98 / 365 (27\%) & 58 / 426 (14\%) & 156 / 791 (20\%) &  \\ 
    Obesity & 53 / 365 (15\%) & 6 / 426 (1.4\%) & 59 / 791 (7.5\%) &  \\ 
\textbf{Dyslipidemia} & 157 / 372 (42\%) & 160 / 427 (37\%) & 317 / 799 (40\%) & 0.17 \\ 
\textbf{Family History of Liver Disease} & 7 / 372 (1.9\%) & 8 / 427 (1.9\%) & 15 / 799 (1.9\%) & >0.99 \\ 
\textbf{Family History of HCC} & 56 / 372 (15\%) & 45 / 427 (11\%) & 101 / 799 (13\%) & 0.055 \\ 
\textbf{HBV viral load} &  &  &  & 0.081 \\ 
    ≤20 IU/mL & 81 / 372 (22\%) & 69 / 427 (16\%) & 150 / 799 (19\%) &  \\ 
    21-2000 IU/mL & 200 / 372 (54\%) & 235 / 427 (55\%) & 435 / 799 (54\%) &  \\ 
    2001-20000 IU/mL & 66 / 372 (18\%) & 78 / 427 (18\%) & 144 / 799 (18\%) &  \\ 
    ≥20000 IU/mL & 25 / 372 (6.7\%) & 45 / 427 (11\%) & 70 / 799 (8.8\%) &  \\ 
\textbf{qAgHBs} &  &  &  & 0.81 \\ 
    <100 IU/mL & 33 / 372 (8.9\%) & 38 / 427 (8.9\%) & 71 / 799 (8.9\%) &  \\ 
    100-1000 IU/mL & 44 / 372 (12\%) & 57 / 427 (13\%) & 101 / 799 (13\%) &  \\ 
    >1000 IU/mL & 295 / 372 (79\%) & 332 / 427 (78\%) & 627 / 799 (78\%) &  \\ 
\textbf{AgHBe} &  &  &  & 0.073 \\ 
    Negative & 367 / 372 (99\%) & 413 / 427 (97\%) & 780 / 799 (98\%) &  \\ 
    Positive & 5 / 372 (1.3\%) & 14 / 427 (3.3\%) & 19 / 799 (2.4\%) &  \\ 
\textbf{HCV Serology} &  &  &  & 0.50 \\ 
    Negative & 372 / 372 (100\%) & 425 / 427 (100\%) & 797 / 799 (100\%) &  \\ 
    Positive & 0 / 372 (0\%) & 2 / 427 (0.5\%) & 2 / 799 (0.3\%) &  \\ 
\textbf{HDV Serology} &  &  &  & 0.76 \\ 
    Negative & 366 / 370 (99\%) & 421 / 427 (99\%) & 787 / 797 (99\%) &  \\ 
    Positive & 4 / 370 (1.1\%) & 6 / 427 (1.4\%) & 10 / 797 (1.3\%) &  \\ 
\textbf{On TDF at Baseline} & 19 / 372 (5.1\%) & 31 / 427 (7.3\%) & 50 / 799 (6.3\%) & 0.21 \\ 
\textbf{ALAT} &  &  &  & 0.024 \\ 
    ≤40 IU/L & 357 / 372 (96\%) & 390 / 427 (91\%) & 747 / 799 (93\%) &  \\ 
    41-80 IU/L & 12 / 372 (3.2\%) & 26 / 427 (6.1\%) & 38 / 799 (4.8\%) &  \\ 
    >80 IU/L & 3 / 372 (0.8\%) & 11 / 427 (2.6\%) & 14 / 799 (1.8\%) &  \\ 
\textbf{APRI Score} &  &  &  & 0.015 \\ 
    Fibrosis & 2 / 372 (0.5\%) & 6 / 427 (1.4\%) & 8 / 799 (1.0\%) &  \\ 
    No Fibrosis & 366 / 372 (98\%) & 404 / 427 (95\%) & 770 / 799 (96\%) &  \\ 
    Unknown & 4 / 372 (1.1\%) & 17 / 427 (4.0\%) & 21 / 799 (2.6\%) &  \\ 
\textbf{FibroScan LSM} &  &  &  & <0.001 \\ 
    F0-1 (no or mild fibrosis) & 359 / 372 (97\%) & 347 / 427 (81\%) & 706 / 799 (88\%) &  \\ 
    F2–3 (significant fibrosis) & 11 / 372 (3.0\%) & 51 / 427 (12\%) & 62 / 799 (7.8\%) &  \\ 
    F4 (cirrhosis) & 2 / 372 (0.5\%) & 29 / 427 (6.8\%) & 31 / 799 (3.9\%) &  \\ 
\textbf{FibroScan CAP} &  &  &  & 0.55 \\ 
    SLD & 34 / 372 (9.1\%) & 34 / 427 (8.0\%) & 68 / 799 (8.5\%) &  \\ 
    Normal & 338 / 372 (91\%) & 393 / 427 (92\%) & 731 / 799 (91\%) &  \\ 
\textbf{UPCR Ratio} &  &  &  & 0.013 \\ 
    Proteinuria (>0.2 mg/mg) & 358 / 372 (96\%) & 393 / 427 (92\%) & 751 / 799 (94\%) &  \\ 
    Normal (<0.2 mg/mg) & 14 / 372 (3.8\%) & 34 / 427 (8.0\%) & 48 / 799 (6.0\%) &  \\ 
\textbf{Leukocyturia (Urine Strips)} &  &  &  & <0.001 \\ 
    Leukocyturia & 173 / 371 (47\%) & 57 / 426 (13\%) & 230 / 797 (29\%) &  \\ 
    Normal & 198 / 371 (53\%) & 369 / 426 (87\%) & 567 / 797 (71\%) &  \\ 
\textbf{Hematuria (Urine Strips)} &  &  &  & <0.001 \\ 
    Hematuria & 68 / 371 (18\%) & 29 / 426 (6.8\%) & 97 / 797 (12\%) &  \\ 
    Normal & 303 / 371 (82\%) & 397 / 426 (93\%) & 700 / 797 (88\%) &  \\ 
\textbf{Proteinuria (Urine Strips)} &  &  &  & 0.62 \\ 
    Proteinuria & 52 / 371 (14\%) & 65 / 426 (15\%) & 117 / 797 (15\%) &  \\ 
    Normal & 319 / 371 (86\%) & 361 / 426 (85\%) & 680 / 797 (85\%) &  \\ 
\textbf{Traditional Medicine} &  &  &  & 0.61 \\ 
    Plant & 119 / 372 (32\%) & 148 / 427 (35\%) & 267 / 799 (33\%) &  \\ 
    Oil/Powder & 1 / 372 (0.3\%) & 2 / 427 (0.5\%) & 3 / 799 (0.4\%) &  \\ 
    None & 252 / 372 (68\%) & 277 / 427 (65\%) & 529 / 799 (66\%) &  \\ 
\textbf{eGFR} &  &  &  & <0.001 \\ 
    ≥60 & 320 / 372 (86\%) & 406 / 427 (95\%) & 726 / 799 (91\%) &  \\ 
    15-60 & 52 / 372 (14\%) & 21 / 427 (4.9\%) & 73 / 799 (9.1\%) &  \\ 
\textbf{cca\_res} &  &  &  & 0.52 \\ 
    Negative & 302 / 332 (91\%) & 359 / 389 (92\%) & 661 / 721 (92\%) &  \\ 
    Positive & 30 / 332 (9.0\%) & 30 / 389 (7.7\%) & 60 / 721 (8.3\%) &  \\ 
\bottomrule
\end{longtable}
\begin{minipage}{\linewidth}
\textsuperscript{\textit{1}}n / N (\%)\\
\textsuperscript{\textit{2}}Fisher's exact test; Pearson's Chi-squared test\\
\end{minipage}

\section{TABLE 2}\label{table-2}

\begin{verbatim}
## 78 observations missing `cca_res` have been removed. To include these observations, use `forcats::fct_na_value_to_level()` on `cca_res` column before passing to `tbl_summary()`.
\end{verbatim}

\setlength{\LTpost}{0mm}
\begin{longtable}{lcccc}
\toprule
 & \multicolumn{2}{c}{\textbf{CCA Result}} &  &  \\ 
\cmidrule(lr){2-3}
\textbf{Variable} & \textbf{Negative}, N = 661\textsuperscript{\textit{1}} & \textbf{Positive}, N = 60\textsuperscript{\textit{1}} & \textbf{Total} (N = 721)\textsuperscript{\textit{1}} & \textbf{p-value}\textsuperscript{\textit{2}} \\ 
\midrule\addlinespace[2.5pt]
\textbf{Screening Year} &  &  &  & <0.001 \\ 
    2019 & 61 / 661 (9.2\%) & 20 / 60 (33\%) & 81 / 721 (11\%) &  \\ 
    2020 & 57 / 661 (8.6\%) & 2 / 60 (3.3\%) & 59 / 721 (8.2\%) &  \\ 
    2021 & 343 / 661 (52\%) & 36 / 60 (60\%) & 379 / 721 (53\%) &  \\ 
    2022 & 195 / 661 (30\%) & 2 / 60 (3.3\%) & 197 / 721 (27\%) &  \\ 
    2023 & 5 / 661 (0.8\%) & 0 / 60 (0\%) & 5 / 721 (0.7\%) &  \\ 
\textbf{Age} &  &  &  & 0.42 \\ 
    18-31 & 317 / 661 (48\%) & 32 / 60 (53\%) & 349 / 721 (48\%) &  \\ 
    >31 & 344 / 661 (52\%) & 28 / 60 (47\%) & 372 / 721 (52\%) &  \\ 
\textbf{sex} &  &  &  & 0.52 \\ 
    Female & 302 / 661 (46\%) & 30 / 60 (50\%) & 332 / 721 (46\%) &  \\ 
    Male & 359 / 661 (54\%) & 30 / 60 (50\%) & 389 / 721 (54\%) &  \\ 
\textbf{Origin} &  &  &  & 0.71 \\ 
    <1\% prevalence (non-endemic) & 230 / 646 (36\%) & 17 / 57 (30\%) & 247 / 703 (35\%) &  \\ 
    1-9.9\% prevalence (low) & 150 / 646 (23\%) & 12 / 57 (21\%) & 162 / 703 (23\%) &  \\ 
    10-49\% prevalence (moderate) & 189 / 646 (29\%) & 19 / 57 (33\%) & 208 / 703 (30\%) &  \\ 
    ≥50\% prevalence (high) & 62 / 646 (9.6\%) & 8 / 57 (14\%) & 70 / 703 (10.0\%) &  \\ 
    Other Country & 15 / 646 (2.3\%) & 1 / 57 (1.8\%) & 16 / 703 (2.3\%) &  \\ 
\textbf{Residence} &  &  &  & 0.22 \\ 
    Dakar & 530 / 661 (80\%) & 52 / 60 (87\%) & 582 / 721 (81\%) &  \\ 
    Outside & 131 / 661 (20\%) & 8 / 60 (13\%) & 139 / 721 (19\%) &  \\ 
\textbf{Alcohol Consumption} &  &  &  & >0.99 \\ 
    Yes\_past & 18 / 631 (2.9\%) & 1 / 59 (1.7\%) & 19 / 690 (2.8\%) &  \\ 
    No & 613 / 631 (97\%) & 58 / 59 (98\%) & 671 / 690 (97\%) &  \\ 
\textbf{AUDIT-C Score} &  &  &  & >0.99 \\ 
    Misuse & 12 / 661 (1.8\%) & 1 / 60 (1.7\%) & 13 / 721 (1.8\%) &  \\ 
    Negative & 649 / 661 (98\%) & 59 / 60 (98\%) & 708 / 721 (98\%) &  \\ 
\textbf{Dipstick EtG} &  &  &  & 0.023 \\ 
    Negative & 494 / 629 (79\%) & 52 / 57 (91\%) & 546 / 686 (80\%) &  \\ 
    Positive & 135 / 629 (21\%) & 5 / 57 (8.8\%) & 140 / 686 (20\%) &  \\ 
\textbf{Drug Consumption} &  &  &  & >0.99 \\ 
    Yes\_now & 0 / 661 (0\%) & 0 / 60 (0\%) & 0 / 721 (0\%) &  \\ 
    Yes\_past & 10 / 661 (1.5\%) & 1 / 60 (1.7\%) & 11 / 721 (1.5\%) &  \\ 
    No & 651 / 661 (98\%) & 59 / 60 (98\%) & 710 / 721 (98\%) &  \\ 
\textbf{Smoking} &  &  &  & 0.45 \\ 
    Yes\_now & 15 / 661 (2.3\%) & 0 / 60 (0\%) & 15 / 721 (2.1\%) &  \\ 
    Yes\_past & 57 / 661 (8.6\%) & 7 / 60 (12\%) & 64 / 721 (8.9\%) &  \\ 
    No & 589 / 661 (89\%) & 53 / 60 (88\%) & 642 / 721 (89\%) &  \\ 
\textbf{Hypertension} & 164 / 661 (25\%) & 11 / 60 (18\%) & 175 / 721 (24\%) & 0.26 \\ 
\textbf{Diabetes} & 18 / 661 (2.7\%) & 2 / 60 (3.3\%) & 20 / 721 (2.8\%) & 0.68 \\ 
\textbf{BMI} &  &  &  & 0.87 \\ 
    Normal Weight & 378 / 655 (58\%) & 35 / 60 (58\%) & 413 / 715 (58\%) &  \\ 
    Underweight & 99 / 655 (15\%) & 10 / 60 (17\%) & 109 / 715 (15\%) &  \\ 
    Overweight & 124 / 655 (19\%) & 12 / 60 (20\%) & 136 / 715 (19\%) &  \\ 
    Obesity & 54 / 655 (8.2\%) & 3 / 60 (5.0\%) & 57 / 715 (8.0\%) &  \\ 
\textbf{Dyslipidemia} & 274 / 661 (41\%) & 20 / 60 (33\%) & 294 / 721 (41\%) & 0.22 \\ 
\textbf{Family History of Liver Disease} & 12 / 661 (1.8\%) & 0 / 60 (0\%) & 12 / 721 (1.7\%) & 0.61 \\ 
\textbf{Family History of HCC} & 86 / 661 (13\%) & 5 / 60 (8.3\%) & 91 / 721 (13\%) & 0.30 \\ 
\textbf{HBV viral load} &  &  &  & 0.98 \\ 
    ≤20 IU/mL & 123 / 661 (19\%) & 10 / 60 (17\%) & 133 / 721 (18\%) &  \\ 
    21-2000 IU/mL & 356 / 661 (54\%) & 33 / 60 (55\%) & 389 / 721 (54\%) &  \\ 
    2001-20000 IU/mL & 123 / 661 (19\%) & 11 / 60 (18\%) & 134 / 721 (19\%) &  \\ 
    ≥20000 IU/mL & 59 / 661 (8.9\%) & 6 / 60 (10\%) & 65 / 721 (9.0\%) &  \\ 
\textbf{qAgHBs} &  &  &  & 0.35 \\ 
    <100 IU/mL & 54 / 661 (8.2\%) & 8 / 60 (13\%) & 62 / 721 (8.6\%) &  \\ 
    100-1000 IU/mL & 85 / 661 (13\%) & 6 / 60 (10\%) & 91 / 721 (13\%) &  \\ 
    >1000 IU/mL & 522 / 661 (79\%) & 46 / 60 (77\%) & 568 / 721 (79\%) &  \\ 
\textbf{AgHBe} &  &  &  & 0.65 \\ 
    Negative & 646 / 661 (98\%) & 58 / 60 (97\%) & 704 / 721 (98\%) &  \\ 
    Positive & 15 / 661 (2.3\%) & 2 / 60 (3.3\%) & 17 / 721 (2.4\%) &  \\ 
\textbf{HCV Serology} &  &  &  & >0.99 \\ 
    Negative & 660 / 661 (100\%) & 60 / 60 (100\%) & 720 / 721 (100\%) &  \\ 
    Positive & 1 / 661 (0.2\%) & 0 / 60 (0\%) & 1 / 721 (0.1\%) &  \\ 
\textbf{HDV Serology} &  &  &  & 0.50 \\ 
    Negative & 653 / 660 (99\%) & 58 / 59 (98\%) & 711 / 719 (99\%) &  \\ 
    Positive & 7 / 660 (1.1\%) & 1 / 59 (1.7\%) & 8 / 719 (1.1\%) &  \\ 
\textbf{On TDF at Baseline} & 41 / 661 (6.2\%) & 2 / 60 (3.3\%) & 43 / 721 (6.0\%) & 0.57 \\ 
\textbf{ALAT} &  &  &  & >0.99 \\ 
    ≤40 IU/L & 616 / 661 (93\%) & 56 / 60 (93\%) & 672 / 721 (93\%) &  \\ 
    41-80 IU/L & 33 / 661 (5.0\%) & 3 / 60 (5.0\%) & 36 / 721 (5.0\%) &  \\ 
    >80 IU/L & 12 / 661 (1.8\%) & 1 / 60 (1.7\%) & 13 / 721 (1.8\%) &  \\ 
\textbf{APRI Score} &  &  &  & 0.30 \\ 
    Fibrosis & 8 / 661 (1.2\%) & 0 / 60 (0\%) & 8 / 721 (1.1\%) &  \\ 
    No Fibrosis & 638 / 661 (97\%) & 57 / 60 (95\%) & 695 / 721 (96\%) &  \\ 
    Unknown & 15 / 661 (2.3\%) & 3 / 60 (5.0\%) & 18 / 721 (2.5\%) &  \\ 
\textbf{FibroScan LSM} &  &  &  & 0.14 \\ 
    F0-1 (no or mild fibrosis) & 580 / 661 (88\%) & 56 / 60 (93\%) & 636 / 721 (88\%) &  \\ 
    F2–3 (significant fibrosis) & 55 / 661 (8.3\%) & 1 / 60 (1.7\%) & 56 / 721 (7.8\%) &  \\ 
    F4 (cirrhosis) & 26 / 661 (3.9\%) & 3 / 60 (5.0\%) & 29 / 721 (4.0\%) &  \\ 
\textbf{FibroScan CAP} &  &  &  & 0.14 \\ 
    SLD & 59 / 661 (8.9\%) & 2 / 60 (3.3\%) & 61 / 721 (8.5\%) &  \\ 
    Normal & 602 / 661 (91\%) & 58 / 60 (97\%) & 660 / 721 (92\%) &  \\ 
\textbf{UPCR Ratio} &  &  &  & 0.041 \\ 
    Proteinuria (>0.2 mg/mg) & 618 / 661 (93\%) & 60 / 60 (100\%) & 678 / 721 (94\%) &  \\ 
    Normal (<0.2 mg/mg) & 43 / 661 (6.5\%) & 0 / 60 (0\%) & 43 / 721 (6.0\%) &  \\ 
\textbf{Leukocyturia (Urine Strips)} &  &  &  & 0.88 \\ 
    Leukocyturia & 193 / 659 (29\%) & 17 / 60 (28\%) & 210 / 719 (29\%) &  \\ 
    Normal & 466 / 659 (71\%) & 43 / 60 (72\%) & 509 / 719 (71\%) &  \\ 
\textbf{Hematuria (Urine Strips)} &  &  &  & 0.67 \\ 
    Hematuria & 78 / 659 (12\%) & 6 / 60 (10\%) & 84 / 719 (12\%) &  \\ 
    Normal & 581 / 659 (88\%) & 54 / 60 (90\%) & 635 / 719 (88\%) &  \\ 
\textbf{Proteinuria (Urine Strips)} &  &  &  & 0.83 \\ 
    Proteinuria & 103 / 659 (16\%) & 10 / 60 (17\%) & 113 / 719 (16\%) &  \\ 
    Normal & 556 / 659 (84\%) & 50 / 60 (83\%) & 606 / 719 (84\%) &  \\ 
\textbf{Traditional Medicine} &  &  &  & 0.72 \\ 
    Plant & 222 / 661 (34\%) & 18 / 60 (30\%) & 240 / 721 (33\%) &  \\ 
    Oil/Powder & 2 / 661 (0.3\%) & 0 / 60 (0\%) & 2 / 721 (0.3\%) &  \\ 
    None & 437 / 661 (66\%) & 42 / 60 (70\%) & 479 / 721 (66\%) &  \\ 
\textbf{eGFR} &  &  &  & 0.32 \\ 
    ≥60 & 599 / 661 (91\%) & 52 / 60 (87\%) & 651 / 721 (90\%) &  \\ 
    15-60 & 62 / 661 (9.4\%) & 8 / 60 (13\%) & 70 / 721 (9.7\%) &  \\ 
\bottomrule
\end{longtable}
\begin{minipage}{\linewidth}
\textsuperscript{\textit{1}}n / N (\%)\\
\textsuperscript{\textit{2}}Fisher's exact test; Pearson's Chi-squared test\\
\end{minipage}

\end{document}
